Key points are not available for this paper at this time.
This study met its primary end point, with an ORR of 38% (P BRAFV600-mutated tumors outside of currently approved indications.
Building similarity graph...
Analyzing shared references across papers
Loading...
April K.S. Salama
Shuli Li
Erin Macrae
Journal of Clinical Oncology
Johns Hopkins University
University of Pennsylvania
Massachusetts General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Salama et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d94d7600ab073a27835ece — DOI: https://doi.org/10.1200/jco.20.00762